EYLEA (AFLIBERCEPT)
$999.00
(In stock)
Aflibercept demonstrated anti-tumor effects and antiangiogenic activity as a single agent and enhanced activity in combination with chemotherapy.
In stock
$999.00
Aflibercept demonstrated anti-tumor effects and antiangiogenic activity as a single agent and enhanced activity in combination with chemotherapy.
In stock
In stock
Reviews
There are no reviews yet.